Our cellular experiments in the present study further confirmed that the knockdown of FDX1 not only reduced elesclomol-Cu-induced DLAT oligomerization but also conferred resistance to copper-induced cell death in HCC cells. This evidence concerns the gene DLAT and hepatocellular carcinoma.